Testing effectiveness (Phase 2)Study completedNCT01158118
What this trial is testing
Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLymphoma, Non-Hodgkin+3 more
Washington University School of Medicine 48